Endocrine Abstracts

Objective: Combined oral contraceptive pills (COCP), primarily used for contraception; are also indicated in other conditions including polycystic ovary syndrome (PCOS). Evidence on the prevalence and patterns of COCP use in PCOS compared to those without the condition are unknown, and studies in unselected populations, especially longitudinally, are very limited. The aim of this study was to examine prevalence and patterns of COCP use in women with PCOS, compared to the backg...

Introduction : Polycystic ovary syndrome (PCOS) is associated with broad reproductive, metabolic and psychological complications, as well as significant heterogeneity in presentation between and within individuals across the lifespan. Therefore, there is a need for a multidisciplinary approach. A model of care (MoC) is conceptualised as an overarching provision of care that is codesigned with end-users and aligns with evidence-based practice and defined standards. The internat...

Background: Hirsutism, characterized by the male pattern distribution of terminal hair in females due to elevated androgen levels, is a diagnostic feature for polycystic ovary syndrome (PCOS), assessed by the modified Ferriman-Gallwey (mFG) score. The 2023 international PCOS guideline suggests an mFG score of 4-6 for hirsutism detection. However, the lack of universally applicable cut-offs in diverse populations necessitates further research. Therefore, this study aimed to def...